News

May 23, 2023

Allucent Launches Decentralized Clinical Trial Solution at 2023 World Orphan Drug Congress

READ MORE

March 14, 2023

Allucent Appoints Alexander J. MacDonald as Vice President of Model-Informed Drug Development

READ MORE

February 27, 2023

Allucent Appoints Life Science Veteran, Bob Millham, to Head Newly Formed Customer Engagement Unit

READ MORE

February 13, 2023

Allucent Appoints Lisa Benincosa as Senior Vice President of Clinical Pharmacology Strategy

READ MORE

January 24, 2023

Allucent Is Now Great Place To Work Certified

READ MORE

January 10, 2023

Allucent Appoints Alexander Berg as Vice President of Clinical Pharmacology Development and Operations

READ MORE

December 12, 2022

Allucent Appoints Sugato De as Vice President of Regulatory Strategy and Head of Medical Technology

READ MORE

October 18, 2022

Allucent Expands Presence in India and Deepens World-Class Operational Functions with Opening of New Office in Chennai

READ MORE

September 6, 2022

Allucent Chairman and CEO Mark A. Goldberg Honored by PharmaVoice as One of the Year’s 100 Most Inspiring People in Life Sciences

READ MORE

August 22, 2022

Allucent Appoints Steffany Cox as Chief Marketing Officer

READ MORE

June 14, 2022

Allucent Appoints President of Clinical Pharmacology, Modeling and Simulation

READ MORE

May 2, 2022

CATO SMS is Now Allucent

READ MORE

January 5, 2022

CATO SMS and Pharm-Olam Merge to Create Global Biopharmaceutical Services Leader

READ MORE

January 5, 2022

CATO SMS AND PHARM-OLAM MERGE TO CREATE GLOBAL BIOPHARMACEUTICAL SERVICES LEADER

READ MORE

December 8, 2021

CATO SMS Appoints Regulatory Strategy Leader in Pharmacology and Toxicology

READ MORE

September 30, 2021

CATO SMS Appoints Vice President of Regulatory Strategy Cell and Gene Therapy

READ MORE

September 13, 2021

CATO SMS Appoints Dr. Teresa Nunes Chief Medical Officer

READ MORE

September 2, 2021

CATO SMS Appoints Vice President of Regulatory Strategy

READ MORE

July 7, 2021

CATO SMS Appoints President of Clinical Trial Operations

READ MORE

June 9, 2021

CATO SMS Appoints Regulatory Strategy Leader

READ MORE

May 26, 2021

CATO SMS Acquires Nuventra To Expand Drug Development Offering Into Clinical Pharmacology

READ MORE

May 20, 2021

Pharm-Olam Enrolling UK Volunteers for Phase 3 Valneva COVID-19 Vaccine Study

READ MORE

March 3, 2021

CATO SMS Announces Consulting Leadership Appointment

READ MORE

January 19, 2021

US Department of Defense selects Pharm-Olam as CRO for Adalimumab COVID Therapeutic Trial

READ MORE

November 24, 2020

LAVA Therapeutics signed agreement with CATO SMS to conduct its Phase I/IIa trial with T-cell engager LAVA-051 in hematologic malignancies

READ MORE

October 8, 2020

BARDA Selects Pharm-Olam to Support Clinical Trial Planning & Execution for up to 5 Years

READ MORE

September 29, 2020

Double Bond Pharmaceutical concludes Key Opinion Leader (KOL) meeting, an important milestone for SI-053 Phase 1 clinical study

READ MORE

September 23, 2020

Pharm-Olam Selected as a CRO for Department of Defense Support to Operation Warp Speed Vaccine Trials, Partnering with Geneva Foundation

READ MORE

September 15, 2020

CATO SMS Acquires Array Biostatistics

READ MORE

September 2, 2020

CATO SMS Unveils New Brand

READ MORE

June 24, 2020

Pharm-Olam Positioning for Growth Trajectory

READ MORE

June 16, 2020

Pharm-Olam Launches New Protocol Optimization Service

READ MORE

May 26, 2020

Cytovation Announces Dosing of First Patient in its Phase I/II CICILIA Trial Investigating CyPep-1 in Patients with Solid Cancers

READ MORE

May 19, 2020

CATO SMS Signs Agreement with InteRNA to Facilitate Phase I Solid Tumor Trial

READ MORE

April 29, 2020

Pharm-Olam recognized by 2020 CRO Leadership Awards second year in a row

READ MORE

April 27, 2020

Accredited Internationally Qualified Clinical Research Auditor Standard Launches

READ MORE

March 26, 2020

Pharm-Olam selected to support Revive Therapeutics development of Bucillamine for COVID-19

READ MORE

March 23, 2020

Pharm-Olam’s Response to COVID-19: Safety, Community, Research

READ MORE

March 16, 2020

COVID-19 CATO SMS OPERATIONS UPDATE

READ MORE

October 28, 2019

CATO Research Announces Merger With SMS-Oncology

READ MORE

October 9, 2019

Pharm-Olam names new CEO, Dr. Robert Davie

READ MORE

August 12, 2019

Importance of Natural History Studies to Rare Disease Drug Development

READ MORE

July 29, 2019

Pharm-Olam Webinar Helps Sponsors Manage Rescue Study Transitions

READ MORE

April 19, 2019

Cato Research Appoints Life Sciences Leader And Innovator To Executive Chairman

READ MORE

April 3, 2019

Pharm-Olam Wins 2019 CRO Leadership Awards

READ MORE

March 6, 2019

Celebrating 25-Year Anniversary and Enhanced Rare Disease Services

READ MORE

February 5, 2019

Pharm-Olam Enrolls Patients in Zealand Pharma Orphan Drug Study

READ MORE

October 30, 2018

Orphan Trial leads to First Therapeutic for the Treatment for aTTP

READ MORE

October 24, 2018

Pharm-Olam Unifies Data on Medidata Cloud, Eliminating Silos

READ MORE

July 31, 2018

Pharm-Olam Supports Clinical Trials and Sponsors Compliance with GDPR

READ MORE

April 27, 2018

Webinar: GDPR Implementation Across Global Clinical Trial Industry

READ MORE

January 11, 2018

Pharm-Olam LLC Appoints Dr. Kelly McKee as Chief Medical Officer

READ MORE

June 13, 2017

2017 Winner in CRO Leadership Awards for Second Consecutive Year

READ MORE

May 31, 2017

Pharm-Olam International Adds John Barry as Chief Operating Officer

READ MORE

March 23, 2017

Pharm-Olam Webinar: Evolution of Response Evaluation Oncology Trials

READ MORE

February 22, 2017

Pharm-Olam LLC Announces New Addition to Lead Biostatistics Team

READ MORE

February 9, 2017

Quad-C Management Announces Investment in Pharm-Olam LLC

READ MORE

January 31, 2017

Using Medidata Rave improves Data Management & Reporting Capabilities

READ MORE

November 16, 2016

Pharm-Olam adds New Addition to Quality and Compliance Leadership Team

READ MORE

November 1, 2016

Webinar: Global Clinical Research Leaders Address Rescue Study Challenges

READ MORE

October 25, 2016

Pharm-Olam Adds Director of Scientific Development

READ MORE

September 27, 2016

Pharm-Olam LLC Nominated for 2016 Scrip Awards Best Full-Service CRO

READ MORE

September 1, 2016

37th Telly Award Winner for Promotion of Allergy Clinical Research

READ MORE

August 17, 2016

Pharm-Olam Bolsters Client Outreach with Proposals and Contracts hire

READ MORE

June 27, 2016

Pharm-Olam International Strengthens Country Leadership with Strategic Hire in Mexico

READ MORE

May 24, 2016

Pharm-Olam International Adds Regional Director, Clinical Operations

READ MORE

May 10, 2016

Pharm-Olam International Awarded Six CRO Leadership Awards

READ MORE

January 12, 2016

Pharm-Olam Continues Global Expansion; Adds Full-Service Coverage in Asia-Pacific Region

READ MORE

December 20, 2015

Pharm-Olam Strengthens Leadership Team with New CFO

READ MORE

October 13, 2015

Pharm-Olam International Expands to Larger Facility in Poland

READ MORE

June 11, 2015

Pharm-Olam International Opens a New Office in Paris, France; Continues Global Expansion

READ MORE

March 12, 2015

Pharm-Olam's Case Study on Automated Sample Retention for BA/BE

READ MORE

February 12, 2015

Pharm-Olam: Phase III Pulmonary Arterial Hypertension study completed

READ MORE

January 12, 2015

Pharm-Olam releases a corporate overview video

READ MORE

November 13, 2014

Webinar: How political events are affecting clinical trials in Ukraine

READ MORE

November 4, 2014

Pharm-Olam International Celebrates 20-Year Anniversary

READ MORE

February 1, 2014

Pharm-Olam completes birch and grass pollen allergy studies

READ MORE

January 13, 2014

Pharm-Olam Expands into Israel

READ MORE

May 30, 2013

Pharm-Olam expands Clinical Trial Services to Kazakhstan

READ MORE